Stock Events

Hadasit Bio-Holdings 

$0.13
2
+$0+0% Thursday 20:00

Statistics

Day High
0.13
Day Low
0.13
52W High
0.27
52W Low
0.13
Volume
200
Avg. Volume
0
Mkt Cap
1.43M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Feb 19
$0.16
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30JunConfirmed
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-0.15
0.01
0.18
0.34
Expected EPS
0
Actual EPS
0.3404

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HSITF. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap19.04B
Teva Pharmaceutical Industries Ltd. is a global leader in generic and specialty medicines, competing directly in the pharmaceutical and biotech sectors.
Redhill Biopharma
RDHL
Mkt Cap320,336
RedHill Biopharma Ltd. operates in the same region and focuses on developing proprietary drugs for inflammatory and gastrointestinal diseases, overlapping with some of Hadasit's therapeutic areas.
Evogene
EVGN
Mkt Cap30.35M
Evogene Ltd. applies computational biology to develop products for life sciences and agriculture, competing in the biotech innovation space similar to Hadasit.
Kamada
KMDA
Mkt Cap332.2M
Kamada Ltd. is a biopharmaceutical company specializing in the development and production of plasma-derived protein therapeutics, a field relevant to Hadasit's interests in biopharmaceuticals.
Protalix BioTherapeutics
PLX
Mkt Cap80.65M
Protalix BioTherapeutics Inc. focuses on the development and commercialization of recombinant therapeutic proteins, which is a direct competition in the biopharmaceutical sector.
Biomarin Pharmaceutical
BMRN
Mkt Cap15.97B
BioMarin Pharmaceutical Inc. develops and commercializes innovative biopharmaceuticals for rare diseases, competing in the specialized biotech market similar to Hadasit.
Regeneron Pharmaceuticals
REGN
Mkt Cap114.81B
Regeneron Pharmaceuticals, Inc. is known for its innovation in biopharmaceuticals, directly competing with Hadasit in the field of novel medical solutions.
Vertex Pharmaceuticals
VRTX
Mkt Cap126.85B
Vertex Pharmaceuticals Incorporated operates in the biotechnology and pharmaceuticals industry, focusing on serious diseases, thus competing in the same broad sector as Hadasit.
AMGEN
AMGN
Mkt Cap177.72B
Amgen Inc. is a leading biotech company focusing on areas like cardiovascular disease, oncology, and bone health, competing in the biopharmaceutical field.
Gilead Sciences
GILD
Mkt Cap90.4B
Gilead Sciences, Inc. develops and markets therapies in areas such as liver disease, HIV, and oncology, overlapping with Hadasit's therapeutic focus areas.

About

Biotechnology
Health Technology
Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It primarily focuses on the therapeutic areas, including oncology, regenerative medicine, and inflammatory disease. The company offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. Hadasit Bio-Holdings Ltd was founded in 2005 and is based in Jerusalem, Israel.
Show more...
CEO
Employees
2
Country
IL
ISIN
IL0010954050

Listings

TA
IL
HDST-M.TA
OTCM
US
HSITF